Status:

RECRUITING

Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a

Lead Sponsor:

Oslo University Hospital

Conditions:

Plantar Fascitis

Gastrocnemius Tightness

Eligibility:

All Genders

18-75 years

Brief Summary

This prospective clinical cohort study will follow 40 patients who recieve botulinum toxin A treatment for proximal medial gastrocnemius tightness with subsequent Chronic Plantar Fasciitis for two yea...

Detailed Description

The connection between gastrocnemius tightness and plantar fasciitis has been demonstrated in several clinical studies. Patients with chronic pathology, and unsatisfactory results from physical therap...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age 18-75 years.
  • An isolated gastrocnemius contracture must be verified with the Silfverskiölds test before inclusion.
  • Diagnosis plantar fasciitis verified clinically by an orthopaedic surgeon.
  • Diagnosis verified by MRI. MRI criteria: Thickening of the plantar fascia, oedema in the calcaneus, pathological signal changes in the plantar fascia (35)
  • Duration of symptoms must be at least 12 months prior to first BTA injection.
  • Conventional Physical Therapy must have been tried at least three months without a significant reduction of symptoms in the affected foot.
  • Exclusion criteria:
  • Previously undergone surgery for plantar fasciitis.
  • Patients with severe talocrural pathology or serious malalignment of foot and ankle
  • Severely reduced peripheral circulation
  • History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent.
  • Patients with a contraindication/non-compliance for MRI examination.
  • History of allergic reaction/anaphylactic reaction or other contraindication to botulinum toxin.
  • Not able to read and/or speak a Scandinavian language or English adequately.

Exclusion

    Key Trial Info

    Start Date :

    January 13 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 1 2026

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT05218785

    Start Date

    January 13 2022

    End Date

    January 1 2026

    Last Update

    March 30 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Oslo University Hospital, Orthopedic Department Ullevål

    Oslo, Oslo County, Norway